Adlai Nortye Ltd. (ANL)
About Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $640.8M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $640.8M
- Dividend yield
- 8.67%
- Shares outstanding
- 55.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 29, 2023
Adlai Nortye Ltd. (ANL) Stock Price
- Trading 31% below its 52-week high.
- Pays a dividend yielding about 8.67% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Adlai Nortye Ltd..
Write a review
News about Adlai Nortye Ltd.
News & sentiment via Polygon.io
Adlai Nortye Ltd.: frequently asked questions
Is Adlai Nortye Ltd. an American company?
Adlai Nortye Ltd. is a US-based company headquartered in North Brunswick, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Adlai Nortye Ltd. headquartered?
Adlai Nortye Ltd. is headquartered in North Brunswick, New Jersey, United States.
Is Adlai Nortye Ltd. publicly traded?
Yes — Adlai Nortye Ltd. is a publicly traded company. Its stock trades under the ticker symbol ANL on the NASDAQ.
What does Adlai Nortye Ltd. do?
Adlai Nortye Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.
